Pieter Nota - Koninklijke Philips CEO
| PHG Stock | USD 19.98 0.17 0.84% |
CEO
Mr. Pieter A. J. Nota was Executive Vice President Chief Executive Officer of Personal Health, Chief Marketing Officer, Member of the Board of Management of Koninklijke Philips NV since April 1, 2011. Prior to his current position, Mr. Nota served as CEO of Consumer Lifestyle and Member of the Group Management Committee. Mr. Nota started his career at Unilever in the Netherlands, as a Brand Manager, in 1990. After becoming a Product Group Manager and National Account Manager, he became the Marketing Manager Innovations Europe for Unilever in the United Kingdom in 1996. From 19982002 he was the Marketing Director and Member of the Executive Board, of Unilever Poland, and from 20022005 he was the Marketing Director and Member of the Executive Board, of Unilever Germany. Between 2005 and 2010, Mr. Nota was an Executive Board Member and Chief Marketing Innovation Officer of Beiersdorf AG, responsible for global Marketing and RD and Sales. Mr. Nota holds a degree in Business Administration. since 2011.
| Age | 52 |
| Tenure | 13 years |
| Address | Philips Center, Amsterdam, Netherlands, 1096 BC |
| Phone | 31 20 597 7777 |
| Web | https://www.philips.com |
Koninklijke Philips Management Efficiency
The Koninklijke Philips' current Return On Tangible Assets is estimated to increase to -0.03. The Koninklijke Philips' current Return On Capital Employed is estimated to increase to -0.0052. At this time, Koninklijke Philips' Total Current Assets are most likely to decrease significantly in the upcoming years. The Koninklijke Philips' current Other Assets is estimated to increase to about 2.5 B, while Non Currrent Assets Other are projected to decrease to roughly 275.5 M. Koninklijke Philips' management efficiency ratios could be used to measure how well Koninklijke Philips manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | CEO Age | ||
| Prahlad Singh | Revvity | 59 | |
| Helmy Eltoukhy | Guardant Health | 44 | |
| Oliver Filliol | Mettler Toledo International | 54 | |
| Michael McMullen | Agilent Technologies | 63 | |
| Marc Casper | Thermo Fisher Scientific | 56 | |
| Patrick Kaltenbach | Mettler Toledo International | 61 | |
| JoAnn Reed | Waters | 64 | |
| Jacob Thaysen | Illumina | 49 | |
| Udit Batra | Waters | 53 | |
Management Performance
| Return On Equity | -0.0358 | ||||
| Return On Asset | 0.0087 |
Koninklijke Philips Leadership Team
Elected by the shareholders, the Koninklijke Philips' board of directors comprises two types of representatives: Koninklijke Philips inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke Philips' management team and ensure that shareholders' interests are well served. Koninklijke Philips' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke Philips' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Cascella, Executive Vice President, Strategic Business Development Leader | ||
| Willem Appelo, Chief Officer | ||
| Leandro Mazzoni, Head Relations | ||
| Andy Ho, Executive Vice President, Chief Market Leader of Philips Greater China | ||
| Cornelis Lede, Member of the Supervisory Board | ||
| M Doherty, Independent Member of the Shariah Supervisory Board | ||
| Shez Partovi, Executive Vice President Chief Innovation and Strategy Officer | ||
| Patrick Kung, Executive Vice President & CEO Philips Greater China and Member of Executive Committee | ||
| Brent Shafer, Executive Vice President - North American Market | ||
| Peter Loescher, Independent Member of the Supervisory Board | ||
| Sophie Bechu, Executive Vice President, Chief Operations Officer | ||
| Daniela Seabrook, Chief Human Resource Officer, Executive Vice President | ||
| Marnix Ginneken, Executive Vice President, Chief Legal & Compliance Officer, Member of the Management Board, Secretary | ||
| Henk Jong, Executive Vice President, Chief Executive Officer - Philips Domestic Appliances | ||
| Jeroen Tas, Executive Vice President Chief Innovation and Strategy Officer | ||
| Franois Houten, Advisor | ||
| David Pyott, Independent Member of the Supervisory Board | ||
| Ewald Kist, Member of the Supervisory Board | ||
| Robin Jansen, Head of Investor Relations | ||
| Neelam Dhawan, Independent Member of the Supervisory Board | ||
| Heino Prondzynski, Independent Member of the Supervisory Board | ||
| Roy Jakobs, Executive Vice President Chief Business Leader - Personal Health | ||
| Ronald Jong, Executive Vice President, Chief Human Resources Officer, Chairman Philips Foundation | ||
| Bert Meurs, Executive Vice President, Chief Business Leader Image Guided Therapy and jointly responsible for Diagnosis & Treatment | ||
| Frans Houten, President CEO and Chairman of the Board of Management and Executive Committee | ||
| Denise Haylor, Chief HR Officer, Executive VP and Member of the Executive Committee | ||
| Indra Nooyi, Independent Member of the Supervisory Board | ||
| Pim Preesman, Head of Investor Relations | ||
| Vitor Rocha, Executive Vice President, Chief Market Leader of Philips North America | ||
| Egbert Acht, Executive Vice President | ||
| Sock Chua, Independent Member of the Supervisory Board | ||
| Jeroen Veer, Independent Chairman of the Supervisory Board | ||
| Christine Poon, Vice Chairman of the Supervisory Board, Secretary, Member of Corporate Governance, Nomination and Selection Committee and Member of Remuneration Committee | ||
| Jim Andrew, Executive Vice President & Chief Strategy and Innovation Officer, Member of Executive Committee | ||
| A Harrison, Independent Member of the Supervisory Board | ||
| Kees Wesdorp, Executive Vice President Chief Business Leader Precision Diagnosis and jointly responsible for Diagnosis & Treatment | ||
| Orit Gadiesh, Independent Member of the Supervisory Board | ||
| Marc Harrison, Independent Member of the Supervisory Board | ||
| Deeptha Khanna, Executive Vice President, Chief Business Leader of Personal Health | ||
| Eric Rondolat, Executive Vice President and CEO Philips Lighting Division, Member of the Executive Committee | ||
| Heidi Sichien, Executive Officer | ||
| Paulus Stoffels, Independent Vice Chairman of the Supervisory Board, Secretary | ||
| Jan Kimpen, Chief Officer | ||
| Francois Houten, President, Chief Executive Officer and Chairman of the Board of Management | ||
| Edwin Paalvast, Executive Vice President, Chief of International Markets | ||
| Jackson Tai, Independent Member of the Supervisory Board | ||
| Sean Carney, Chief Officer | ||
| Feike Sijbesma, Independent Vice Chairman of the Supervisory Board | ||
| Pieter Nota, Chief Marketing Officer, Executive Vice-President, Member of Board of Management, Member of The Executive Committee and CEO of Philips Consumer Lifestyle | ||
| Abhijit Bhattacharya, Executive Vice President & Chief Financial Officer, Member of the Management Board | ||
| Carla Kriwet, Executive Vice President Chief Business Leader of Connected Care & Health Informatics (CCHI) Businesses |
Koninklijke Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Koninklijke Philips a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0358 | ||||
| Return On Asset | 0.0087 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 23.96 B | ||||
| Shares Outstanding | 906.4 M | ||||
| Shares Owned By Insiders | 15.36 % | ||||
| Shares Owned By Institutions | 7.75 % | ||||
| Number Of Shares Shorted | 1.96 M | ||||
| Price To Earning | 33.57 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Koninklijke Philips in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Koninklijke Philips' short interest history, or implied volatility extrapolated from Koninklijke Philips options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Koninklijke Philips using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Koninklijke Philips NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Koninklijke Philips information on this page should be used as a complementary analysis to other Koninklijke Philips' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Koninklijke Stock analysis
When running Koninklijke Philips' price analysis, check to measure Koninklijke Philips' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Koninklijke Philips is operating at the current time. Most of Koninklijke Philips' value examination focuses on studying past and present price action to predict the probability of Koninklijke Philips' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Koninklijke Philips' price. Additionally, you may evaluate how the addition of Koninklijke Philips to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Koninklijke Philips' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Koninklijke Philips. If investors know Koninklijke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Koninklijke Philips listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.72) | Earnings Share (0.51) | Revenue Per Share 19.804 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0087 |
The market value of Koninklijke Philips is measured differently than its book value, which is the value of Koninklijke that is recorded on the company's balance sheet. Investors also form their own opinion of Koninklijke Philips' value that differs from its market value or its book value, called intrinsic value, which is Koninklijke Philips' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Koninklijke Philips' market value can be influenced by many factors that don't directly affect Koninklijke Philips' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Koninklijke Philips' value and its price as these two are different measures arrived at by different means. Investors typically determine if Koninklijke Philips is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Koninklijke Philips' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.